There's nothing we journalist types like better than a good-old-fashioned he said, she said story. The tension. The name-calling. The finger pointing. It all makes for good drama, which in turn makes for great headlines. And if the story involves two former business partners, associates or colleagues, well, that's all the better. Why else would the Charlie Sheen-CBS saga command 24-hour news coverage? And is there any other rational explanation for the fact that Sheen now has 2.4 million followers on Twitter?
While it may not rival the Sheen-CBS hysteria, we have our own share of headline-grabbing stories in health care these days, most of them full of bravado and hyperbole surrounding health reform. There's another drama playing out that hasn't received quite the same level of coverage, but could have a huge impact on that cost curve everyone keeps talking about. Back in late February, medical device manufacturer Medtronic Inc. cancelled its contracts with several GPOs. I know, I know. Whoopee, a supply chain story. But we both know that aside from labor, the supply chain represents a hospital's largest line item and one where there's still considerable opportunity to generate savings.
There's been a fair amount of discussion on the blogosphere about whether we'll now see a rash of manufacturers cutting ties with GPOs and doing more direct sales with hospitals. Only time will tell if this is a harbinger of things to come or an isolated situation, but the finger wagging and name calling has blunted a more significant issue that lies just beneath the surface: transparency.
There is a dearth of information available to the public, let alone hospitals, on the cost of medical devices. For years, hospital materials managers have been signing supply contracts that prevent them from releasing any pricing information. GPOs presumably bring some balance to the equation by negotiating bulk discounts with vendors, but typically the GPOs also keep quiet on the details. Every few years, the situation garners attention from lawmakers, as our now-defunct sister publication Materials Management reported in 2009. Last fall, the Government Accountability Office got into the action, issuing a report that closely examined GPO practices and transparency.
Overall, the lack of transparency prevents hospitals from doing their full due diligence and comparison-shopping, let alone ensure that they are leveraging fair prices. The result is tremendous cost variation, as the ECRI Institute revealed in another article in Materials Management.
As we see in the current debate coming from D.C., the larger cost problem vexing health care is not going away any time soon. As the financing system evolves, particularly to global or bundled payments, the supply chain is certain to be drawn into the debate. That's been the experience of hospitals in early demonstrations on bundled payments. The first place they looked for savings was the supply chain. So the question is: Whether it is a vendor or GPO knocking on the door, how much longer can the system support the status quo? E-mail your thoughts to firstname.lastname@example.org.
H&HN Senior Online Editor
H&HN Managing Editor
H&HN Senior Editor
- I'll Take My Business Elsewhere
- Don't Use That Kind of Language Here
- Age Rage: How Does Any Work Get Done?
- When Employee Satisfaction Means Firing a Doctor
- Medicaid on the Chopping Block
- ACHE 2011: Disparities Reduction Moves From Luxury...
- Making Him Better Ruined His Life
- ACHE Chair: Safety Alarmists Scare Some From Seeki...
- Friday Data Snapshot: U.S. Life Expectancy Reaches...
- Have You Gone the Extra Mile?
- Would You Live-Stream a Surgery?
- I Can't Work With Anybody That Age (3 Questions)
- Study: Doctors' empathy tied to better outcomes
- Friday Data Snapshot: CDC Identifies 'Diabetes Bel...
- The Actual Retail Price Is...
- Is It Time For The Kindler, Gentler CEO?
- 'All I Wanted to Know: Is Mom Still Alive?’
- As ACO Rules Loom, Skepticism Sets In
- iPads at the bedside
- Is Patient Safety Part of Your DNA?
- Patients Catch Up to Information Age
- Martha Stewart, Mount Sinai and You
- ▼ March (22)